Chelsea agree personal terms with Ajax winger


Chelsea agree personal terms with Ajax winger
FILE PHOTO: Soccer Football - Champions League - Group H - Chelsea v Ajax Amsterdam - Stamford Bridge, London, Britain - November 5, 2019 Ajax's Hakim Ziyech celebrates their third goal REUTERS/David Klein/File Photo

In Summary

  • Chelsea have agreed personal terms with Ajax winger Hakim Ziyech over a five-year-deal which will see the Morocco international move to Stamford Bridge for 40m euros (£33.3m) in the summer.
  • The clubs reached an agreement for 26-year-old Ziyech, who will remain at the Eredivisie leaders for the rest of the season, earlier this month.

Chelsea have agreed personal terms with Ajax winger Hakim Ziyech over a five-year-deal which will see the Morocco international move to Stamford Bridge for 40m euros (£33.3m) in the summer.

The clubs reached an agreement for 26-year-old Ziyech, who will remain at the Eredivisie leaders for the rest of the season, earlier this month.

“I am proud to have signed for such a huge club as Chelsea,” said Ziyech.

“I am looking forward to next season and hope we can achieve great things.”

Ziyech has scored nine goals in all competitions for Ajax this season, contributing to three goals as the Dutch side drew 4-4 against Chelsea in the Champions League in November.

Hakim Ziyech: The street footballer set to become Chelsea’s next big-money signing

He had been a January transfer target for Chelsea as the Blues suffered a frustrating window and subsequently becomes manager Frank Lampard’s first signing after the club’s transfer ban.

Chelsea director Marina Granovskaia added: “We are delighted Hakim will be joining us in the summer, having been a key target of the club’s in this last window.

“He has consistently been one of the most dangerous attacking players in Europe in recent years, which we saw first-hand in our two games against Ajax in the Champions League.”

Courtesy- BBC Online

For Citizen TV updates
Join @citizentvke Telegram channel



Video Of The Day: KEMRI scientists examine safety of anti-malarial drugs in first trimester of pregnancy

Avatar
Story By Agencies
More by this author